Drug Safety: Sequential Surveillance Helps Regulatory Decision-Making, But Hurt By Premature Specification
Executive Summary
US FDA and academic researchers say unknowns related to certain product aspects make it difficult to form a hypothesis in formal sequential surveillance designs.